GSK3B and Myocardial fibrosis: These findings demonstrate the important role of GSK3β in maintaining β-catenin homeostasis in cells during cardiac fibrosis and suggest that the GSK3β/β-catenin signaling pathway represents a therapeutic target for treating myocardial fibrosis.